Jones M - Search Results

1

The establishment, characterization and calibration of human ovarian carcinoma xenografts for the evaluation of novel platinum anticancer drugs.

Harrap KR, Jones M, Siracky J, Pollard LA, Kelland LR. Harrap KR, et al. Among authors: jones m. Ann Oncol. 1990;1(1):65-76. doi: 10.1093/oxfordjournals.annonc.a057678. Ann Oncol. 1990. PMID: 2078487 Free article.

2

Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.

Jones M, Siracky J, Kelland LR, Harrap KR. Jones M, et al. Br J Cancer. 1993 Jan;67(1):24-9. doi: 10.1038/bjc.1993.5. Br J Cancer. 1993. PMID: 8427780 Free PMC article.

3

Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery.

Kelland LR, Jones M, Abel G, Valenti M, Gwynne J, Harrap KR. Kelland LR, et al. Among authors: jones m. Cancer Chemother Pharmacol. 1992;30(1):43-50. doi: 10.1007/BF00686484. Cancer Chemother Pharmacol. 1992. PMID: 1586979

4

Platinum coordination complexes which circumvent cisplatin resistance.

Harrap KR, Kelland LR, Jones M, Goddard PM, Orr RM, Morgan SE, Murrer BA, Abrams MJ, Giandomenico CM, Cobbleigh T. Harrap KR, et al. Among authors: jones m. Adv Enzyme Regul. 1991;31:31-43. doi: 10.1016/0065-2571(91)90007-9. Adv Enzyme Regul. 1991. PMID: 1877393

5

A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.

Kelland LR, Barnard CF, Mellish KJ, Jones M, Goddard PM, Valenti M, Bryant A, Murrer BA, Harrap KR. Kelland LR, et al. Among authors: jones m. Cancer Res. 1994 Nov 1;54(21):5618-22. Cancer Res. 1994. PMID: 7923207

6

Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo.

McKeage MJ, Kelland LR, Boxall FE, Valenti MR, Jones M, Goddard PM, Gwynne J, Harrap KR. McKeage MJ, et al. Among authors: jones m. Cancer Res. 1994 Aug 1;54(15):4118-22. Cancer Res. 1994. PMID: 8033145

7

Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat.

McKeage MJ, Boxall FE, Jones M, Harrap KR. McKeage MJ, et al. Among authors: jones m. Cancer Res. 1994 Feb 1;54(3):629-31. Cancer Res. 1994. PMID: 8306321

8

Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.

Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR. Kelland LR, et al. Among authors: jones m. Cancer Res. 1993 Jun 1;53(11):2581-6. Cancer Res. 1993. PMID: 8388318

9

cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.

Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR. Raynaud FI, et al. Among authors: jones m. Clin Cancer Res. 1997 Nov;3(11):2063-74. Clin Cancer Res. 1997. PMID: 9815598

10

Antitumor-activity of orally-administered ammine amine platinum (iv) dicarboxylate complexes against a panel of human ovarian-carcinoma xenografts.

Kelland L, Jones M, Gwynne J, Valenti M, Murrer B, Barnard C, Vollano J, Giandomenico C, Abrams M, Harrap K. Kelland L, et al. Among authors: jones m. Int J Oncol. 1993 Jun;2(6):1043-8. doi: 10.3892/ijo.2.6.1043. Int J Oncol. 1993. PMID: 21573668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,316 results

Search Page

Filters